Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
Open accessThe DOI matches its Crossref record; 135 of the 136 references it cites were found in a registry or an index.
Abstract
The state of the art in identifying protein–protein interaction inhibitors of hypoxia inducible factor – a promising target for anticancer drug design – is described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One of the most commonly used PPI inhibitors and E3 ligase ligands is derived from a PTM bearing peptide, hydroxylated HIF-1α [33], thus proving the possibility of developing inhibitors for this type of interaction.”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedRETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
(1999) · PubMed · Cited by 2,204
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
Searching for Peptide Ligands with an Epitope Library
Scott, J. K., & Smith, G. P. (1990) · Science · doi:10.1126/science.1696028 · Cited by 2,084
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
CBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., Garcia, J. G. N., & Semenza, G. L. (2005) · Blood · doi:10.1182/blood-2004-07-2958 · Cited by 1,154
Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1
Jiang, B.-H., Rue, E., Wang, G. L., Roe, R., & Semenza, G. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17771 · Cited by 1,106
Chemistry: Chemical con artists foil drug discovery
Baell, J., & Walters, M. A. (2014) · Nature · doi:10.1038/513481a · Cited by 1,043
Oxygen Sensing, Homeostasis, and Disease
Semenza, G. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011165 · Cited by 993
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Peptides on phage: a vast library of peptides for identifying ligands.
Cwirla, S. E., Peters, E. A., Barrett, R. W., & Dower, W. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6378 · Cited by 928
Random Peptide Libraries: a Source of Specific Protein Binding Molecules
Devlin, J. J., Panganiban, L. C., & Devlin, P. E. (1990) · Science · doi:10.1126/science.2143033 · Cited by 922
Zhang, H., Gao, P., Fukuda, R., Kumar, G., Krishnamachary, B., Zeller, K. I., Dang, C. V., & Semenza, G. L. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.001 · Cited by 885
CREB-binding Protein and p300 in Transcriptional Regulation
Vo, N., & Goodman, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r000025200 · Cited by 866
Signal transduction to hypoxia-inducible factor 1
Semenza, G. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01168-1 · Cited by 860
An essential role for p300/CBP in the cellular response to hypoxia
Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12969 · Cited by 790
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.1073440 · Cited by 765
Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751
Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs
Wiesener, M. S., Jürgensen, J. S., Rosenberger, C., Scholze, C., Hörstrup, J. H., Warnecke, C., Mandriota, S., Bechmann, I., Frei, U. A., Pugh, C. W., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0445fje · Cited by 740
Hypoxia: A key regulator of angiogenesis in cancer
Liao, D., & Johnson, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9066-y · Cited by 721
Targeting renal cell carcinoma with a HIF-2 antagonist
Chen, W., Hill, H., Christie, A., Kim, M. S., Holloman, E., Pavia-Jimenez, A., Homayoun, F., Ma, Y., Patel, N., Yell, P., et al. (2016) · Nature · doi:10.1038/nature19796 · Cited by 709
Oxygen Transport to Tissue: Instrumentation, Methods, and Physiology
(1973) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-3288-6 · Cited by 702
Small‐Molecule PROTACS: New Approaches to Protein Degradation
Toure, M., & Crews, C. M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201507978 · Cited by 674
Kallio, P. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6573 · Cited by 666
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
Semenza, G. L. (2000) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230091169186 · Cited by 654
Recognition of the DNA minor groove by pyrrole-imidazole polyamides
Dervan, P. B., & Edelson, B. S. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00081-2 · Cited by 633
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809763105 · Cited by 624
Buckley, D. L., Van Molle, I., Gareiss, P. C., Tae, H. S., Michel, J., Noblin, D. J., Jorgensen, W. L., Ciulli, A., & Crews, C. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209924v · Cited by 569
Ivan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Günzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192342099 · Cited by 561
PAS is a dimerization domain common to Drosophila Period and several transcription factors
Huang, Z. J., Edery, I., & Rosbash, M. (1993) · Nature · doi:10.1038/364259a0 · Cited by 512
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
Kong, D., Park, E. J., Stephen, A. G., Calvani, M., Cardellina, J. H., Monks, A., Fisher, R. J., Shoemaker, R. H., & Melillo, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1235 · Cited by 508
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
Kung, A. L., Zabludoff, S. D., France, D. S., Freedman, S. J., Tanner, E. A., Vieira, A., Cornell-Kennon, S., Lee, J., Wang, B., Wang, J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.009 · Cited by 480
Gradin, K., McGuire, J., Wenger, R. H., Kvietikova, I., Whitelaw, M. L., Toftgård, R., Tora, L., Gassmann, M., & Poellinger, L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5221 · Cited by 470
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α
Freedman, S. J., Sun, Z.-Y. J., Poy, F., Kung, A. L., Livingston, D. M., Wagner, G., & Eck, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082117899 · Cited by 455
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Cho, H., Du, X., Rizzi, J. P., Liberzon, E., Chakraborty, A. A., Gao, W., Carvo, I., Signoretti, S., Bruick, R. K., Josey, J. A., et al. (2016) · Nature · doi:10.1038/nature19795 · Cited by 451
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Wang, Y., Liu, Y., Malek, S. N., Zheng, P., & Liu, Y. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.02.006 · Cited by 410
Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response
Dames, S. A., Martinez-Yamout, M., De Guzman, R. N., Dyson, H. J., & Wright, P. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082121399 · Cited by 402
Galdeano, C., Gadd, M. S., Soares, P., Scaffidi, S., Van Molle, I., Birced, I., Hewitt, S., Dias, D. M., & Ciulli, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5011258 · Cited by 399
Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1
Bhattacharya, S., Michels, C. L., Leung, M.-K., Arany, Z. P., Kung, A. L., & Livingston, D. M. (1999) · Genes & Development · doi:10.1101/gad.13.1.64 · Cited by 395
Elkins, J. M., Hewitson, K. S., McNeill, L. A., Seibel, J. F., Schlemminger, I., Pugh, C. W., Ratcliffe, P. J., & Schofield, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200644200 · Cited by 391
Biological consequences of tumor hypoxia
HOCKEL, M. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90211-8 · Cited by 382
Structural integration in hypoxia-inducible factors
Wu, D., Potluri, N., Lu, J., Kim, Y., & Rastinejad, F. (2015) · Nature · doi:10.1038/nature14883 · Cited by 346
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Wallace, E. M., Rizzi, J. P., Han, G., Wehn, P. M., Cao, Z., Du, X., Cheng, T., Czerwinski, R. M., Dixon, D. D., Goggin, B. S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0473 · Cited by 336
Hypoxia-inducible Factor and Its Biomedical Relevance
Huang, L. E., & Bunn, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200030200 · Cited by 315
Allosteric inhibition of hypoxia inducible factor-2 with small molecules
Scheuermann, T. H., Li, Q., Ma, H.-W., Key, J., Zhang, L., Chen, R., Garcia, J. A., Naidoo, J., Longgood, J., Frantz, D. E., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1185 · Cited by 315
Hypoxia inducible factor-1α as a cancer drug target
Powis, G., & Kirkpatrick, L. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.647.3.5 · Cited by 311
Wang, F., Marshall, C. B., & Ikura, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1254-4 · Cited by 309
Koh, M. Y., Spivak-Kroizman, T., Venturini, S., Welsh, S., Williams, R. R., Kirkpatrick, D. L., & Powis, G. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0463 · Cited by 309
Small‐Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α
Buckley, D. L., Gustafson, J. L., Van Molle, I., Roth, A. G., Tae, H. S., Gareiss, P. C., Jorgensen, W. L., Ciulli, A., & Crews, C. M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201206231 · Cited by 302
Artificial ligand binding within the HIF2α PAS-B domain of the HIF2 transcription factor
Scheuermann, T. H., Tomchick, D. R., Machius, M., Guo, Y., Bruick, R. K., & Gardner, K. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808092106 · Cited by 301
Provenzano, R., Besarab, A., Sun, C. H., Diamond, S. A., Durham, J. H., Cangiano, J. L., Aiello, J. R., Novak, J. E., Lee, T., Leong, R., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06890615 · Cited by 290
Dales, J.-P., Garcia, S., Meunier-Carpentier, S., Andrac-Meyer, L., Haddad, O., Lavaut, M.-N., Allasia, C., Bonnier, P., & Charpin, C. (2005) · International Journal of Cancer · doi:10.1002/ijc.20984 · Cited by 261
Patgiri, A., Jochim, A. L., & Arora, P. S. (2008) · Accounts of Chemical Research · doi:10.1021/ar700264k · Cited by 251
Franovic, A., Gunaratnam, L., Smith, K., Robert, I., Patten, D., & Lee, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702387104 · Cited by 250
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
Greenberger, L. M., Horak, I. D., Filpula, D., Sapra, P., Westergaard, M., Frydenlund, H. F., Albæk, C., Schrøder, H., & Ørum, H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0510 · Cited by 245
Structural Basis for Binding of Hypoxia-Inducible Factor to the Oxygen-Sensing Prolyl Hydroxylases
Chowdhury, R., McDonough, M. A., Mecinović, J., Loenarz, C., Flashman, E., Hewitson, K. S., Domene, C., & Schofield, C. J. (2009) · Structure · doi:10.1016/j.str.2009.06.002 · Cited by 239
Frost, J., Galdeano, C., Soares, P., Gadd, M. S., Grzes, K. M., Ellis, L., Epemolu, O., Shimamura, S., Bantscheff, M., Grandi, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms13312 · Cited by 239
Van Molle, I., Thomann, A., Buckley, D. L., So, E. C., Lang, S., Crews, C. M., & Ciulli, A. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.015 · Cited by 188
Miranda, E., Nordgren, I. K., Male, A. L., Lawrence, C. E., Hoakwie, F., Cuda, F., Court, W., Fox, K. R., Townsend, P. A., Packham, G. K., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja402993u · Cited by 185
Induction of Phosphoglycerate Kinase 1 Gene Expression by Hypoxia
Li, H., Ko, H. P., & Whitlock, J. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21262 · Cited by 173
Rapisarda, A., Hollingshead, M., Uranchimeg, B., Bonomi, C. A., Borgel, S. D., Carter, J. P., Gehrs, B., Raffeld, M., Kinders, R. J., Parchment, R., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0274 · Cited by 171
Split-intein mediated circular ligation used in the synthesis of cyclic peptide libraries in E. coli
Tavassoli, A., & Benkovic, S. J. (2007) · Nature Protocols · doi:10.1038/nprot.2007.152 · Cited by 171
Sapra, P., Zhao, H., Mehlig, M., Malaby, J., Kraft, P., Longley, C., Greenberger, L. M., & Horak, I. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4456 · Cited by 168
Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications
Tiede, C., Tang, A. A. S., Deacon, S. E., Mandal, U., Nettleship, J. E., Owen, R. L., George, S. E., Harrison, D. J., Owens, R. J., Tomlinson, D. C., et al. (2014) · Protein Engineering, Design and Selection · doi:10.1093/protein/gzu007 · Cited by 163
Shin, D. H., Chun, Y.-S., Lee, D. S., Huang, L. E., & Park, J.-W. (2008) · Blood · doi:10.1182/blood-2007-11-120576 · Cited by 162
Hypersensitive termination of the hypoxic response by a disordered protein switch
Berlow, R. B., Dyson, H. J., & Wright, P. E. (2017) · Nature · doi:10.1038/nature21705 · Cited by 162
Cook, K. M., Hilton, S. T., Mecinović, J., Motherwell, W. B., Figg, W. D., & Schofield, C. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009498 · Cited by 161
Persistent induction of HIF‐1α and ‐2α in cardiomyocytes and stromal cells of ischemic myocardium
Jürgensen, J. S., Rosenberger, C., Wiesener, M. S., Warnecke, C., Hörstrup, J. H., Gräfe, M., Philipp, S., Griethe, W., Maxwell, P. H., Frei, U. A., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1605fje · Cited by 159
Selective Inhibition of Factor Inhibiting Hypoxia-Inducible Factor
McDonough, M. A., McNeill, L. A., Tilliet, M., Papamicaël, C. A., Chen, Q., Banerji, B., Hewitson, K. S., & Schofield, C. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja050841b · Cited by 159
Modulating Hypoxia-Inducible Transcription by Disrupting the HIF-1–DNA Interface
Nickols, N. G., Jacobs, C. S., Farkas, M. E., & Dervan, P. B. (2007) · ACS Chemical Biology · doi:10.1021/cb700110z · Cited by 145
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Chowdhury, R., Leung, I. K. H., Tian, Y.-M., Abboud, M. I., Ge, W., Domene, C., Cantrelle, F.-X., Landrieu, I., Hardy, A. P., Pugh, C. W., et al. (2016) · Nature Communications · doi:10.1038/ncomms12673 · Cited by 145
Molecular Mechanism of Hypoxia-inducible Factor 1α-p300 Interaction
Gu, J., Milligan, J., & Huang, E. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009522200 · Cited by 143
Deep sequencing analysis of phage libraries using Illumina platform
Matochko, W. L., Chu, K., Jin, B., Lee, S. W., Whitesides, G. M., & Derda, R. (2012) · Methods · doi:10.1016/j.ymeth.2012.07.006 · Cited by 138
Functional Analysis of Hypoxia-inducible Factor-1α-mediated Transactivation
Ruas, J. L., Poellinger, L., & Pereira, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205051200 · Cited by 137
Hypoxia-mediated Selective mRNA Translation by an Internal Ribosome Entry Site-independent Mechanism
Young, R. M., Wang, S.-J., Gordan, J. D., Ji, X., Liebhaber, S. A., & Simon, M. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710079200 · Cited by 137
Principles of Ligand Binding within a Completely Buried Cavity in HIF2α PAS-B
Key, J., Scheuermann, T. H., Anderson, P. C., Daggett, V., & Gardner, K. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9073062 · Cited by 136
Henchey, L. K., Kushal, S., Dubey, R., Chapman, R. N., Olenyuk, B. Z., & Arora, P. S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9082864 · Cited by 136
Development of Inhibitors of the PAS-B Domain of the HIF-2α Transcription Factor
Rogers, J. L., Bayeh, L., Scheuermann, T. H., Longgood, J., Key, J., Naidoo, J., Melito, L., Shokri, C., Frantz, D. E., Bruick, R. K., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301847z · Cited by 134
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
Chan, M. C., Holt‐Martyn, J. P., Schofield, C. J., & Ratcliffe, P. J. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.01.001 · Cited by 133
Tanaka, T., Wiesener, M. S., Bernhardt, W. M., Eckardt, K., & Warnecke, C. (2009) · Biochemical Journal · doi:10.1042/bj20090120 · Cited by 129
Rational Design of Topographical Helix Mimics as Potent Inhibitors of Protein–Protein Interactions
Lao, B. B., Drew, K., Guarracino, D. A., Brewer, T. F., Heindel, D. W., Bonneau, R., & Arora, P. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502310r · Cited by 125
Bragança, J., Swingler, T. E., Marques, F. I. R., Jones, T. A., Eloranta, J. J., Hurst, H. C., Shioda, T., & Bhattacharya, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110850200 · Cited by 119
Selective Small Molecule Probes for the Hypoxia Inducible Factor (HIF) Prolyl Hydroxylases
Chowdhury, R., Candela-Lena, J. I., Chan, M. C., Greenald, D. J., Yeoh, K. K., Tian, Y.-M., McDonough, M. A., Tumber, A., Rose, N. R., Conejo-Garcia, A., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400088q · Cited by 116
Xiang, L., Gilkes, D. M., Chaturvedi, P., Luo, W., Hu, H., Takano, N., Liang, H., & Semenza, G. L. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1102-5 · Cited by 114
In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics
Lao, B. B., Grishagin, I., Mesallati, H., Brewer, T. F., Olenyuk, B. Z., & Arora, P. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402393111 · Cited by 112
Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling
Kushal, S., Lao, B. B., Henchey, L. K., Dubey, R., Mesallati, H., Traaseth, N. J., Olenyuk, B. Z., & Arora, P. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312473110 · Cited by 109
The human oxygen sensing machinery and its manipulation
Chowdhury, R., Hardy, A., & Schofield, C. J. (2008) · Chemical Society Reviews · doi:10.1039/b701676j · Cited by 109
Beppu, K., Nakamura, K., Linehan, W. M., Rapisarda, A., & Thiele, C. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3332 · Cited by 96
Current Status of Knowledge and Critical Issues in Tumor Oxygenation
Vaupel, P. W., Thews, O., Kelleher, D. K., & Hoeckel, M. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4863-8_70 · Cited by 91
Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2
Scheuermann, T. H., Stroud, D., Sleet, C. E., Bayeh, L., Shokri, C., Wang, H., Caldwell, C. G., Longgood, J., MacMillan, J. B., Bruick, R. K., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00529 · Cited by 87
N-alkylated oligoamide α-helical proteomimetics
Campbell, F., Plante, J. P., Edwards, T. A., Warriner, S. L., & Wilson, A. J. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c001164a · Cited by 85
Self-citationRuas, J. L., Berchner‐Pfannschmidt, U., Malik, S., Gradin, K., Fandrey, J., Roeder, R. G., Pereira, T., & Poellinger, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021824 · Cited by 82
Partch, C. L., & Gardner, K. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101357108 · Cited by 82
Yin, S., Kaluz, Š., Devi, N. S., Jabbar, A. A., de Noronha, R. G., Mun, J.-Y., Zhang, Z., Boreddy, P. R., Wang, W., Wang, Z., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0861 · Cited by 80
Cardoso, R., Love, R., Nilsson, C. L., Bergqvist, S., Nowlin, D., Yan, J., Liu, K. K. ‐., Zhu, J., Chen, P., Deng, Y., et al. (2012) · Protein Science · doi:10.1002/pro.2172 · Cited by 79
Small‐Molecule Proteomimetic Inhibitors of the HIF‐1α–p300 Protein–Protein Interaction
Burslem, G. M., Kyle, H. F., Breeze, A. L., Edwards, T. A., Nelson, A. S., Warriner, S. L., & Wilson, A. J. (2014) · ChemBioChem · doi:10.1002/cbic.201400009 · Cited by 77
Self-citationTargeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor
Nordgren, I. K., & Tavassoli, A. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15032d · Cited by 76
Beischlag, T. V., Taylor, R. T., Rose, D. W., Yoon, D., Chen, Y., Lee, W.-H., Rosenfeld, M. G., & Hankinson, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410456200 · Cited by 74
Cho, H.-J., Ahn, D., Park, H., & Yang, E. G. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.015 · Cited by 70
Dubey, R., Levin, M. D., Szabó, L., László, C., Kushal, S., Singh, J. B., Oh, P., Schnitzer, J. E., & Olenyuk, B. Z. (2013) · Journal of the American Chemical Society · doi:10.1021/ja400805b · Cited by 64
Hewitson, K. S., Holmes, S. L., Ehrismann, D., Hardy, A., Chowdhury, R., Schofield, C. J., & McDonough, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804999200 · Cited by 60
Concellón, A., Blasco, E., Martínez-Felipe, A., Martínez, J. C., Šics, I., Ezquerra, T. A., Nogales, A., Piñol, M., & Oriol, L. T. (2016) · Macromolecules · doi:10.1021/acs.macromol.6b01112 · Cited by 59
Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway
Mooring, S. R., Jin, H., Devi, N. S., Jabbar, A. A., Kaluz, Š., Liu, Y., Meir, E. G. V., & Wang, B. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201018g · Cited by 53
Depsipeptide substrates for sortase-mediated N-terminal protein ligation
Williamson, D. J., Webb, M. E., & Turnbull, W. B. (2014) · Nature Protocols · doi:10.1038/nprot.2014.003 · Cited by 50
2-O-Alkylated para-benzamide α-helix mimetics: the role of scaffold curvature
Azzarito, V., Prabhakaran, P., Bartlett, A. I., Murphy, N. S., Hardie, M. J., Kilner, C. A., Edwards, T. A., Warriner, S. L., & Wilson, A. J. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob26262b · Cited by 49
Self-citationJayatunga, M. K. P., Thompson, S., McKee, T. C., Chan, M. C., Reece, K. M., Hardy, A., Sekirnik, R., Seden, P. T., Cook, K. M., McMahon, J. B., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.006 · Cited by 49
Guo, Y., Partch, C. L., Key, J., Card, P. B., Pashkov, V., Patel, A., Bruick, R. K., Wurdak, H., & Gardner, K. H. (2013) · ACS Chemical Biology · doi:10.1021/cb300604u · Cited by 47
Role of the Coiled-coil Coactivator (CoCoA) in Aryl Hydrocarbon Receptor-mediated Transcription
Kim, J., & Stallcup, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408535200 · Cited by 43
Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies
Kyle, H. F., Wickson, K. F., Stott, J., Burslem, G. M., Breeze, A. L., Tiede, C., Tomlinson, D. C., Warriner, S. L., Nelson, A. S., Wilson, A. J., et al. (2015) · Molecular BioSystems · doi:10.1039/c5mb00284b · Cited by 42
Self-citationYang, C., Wang, W., Chen, L., Liang, J., Lin, S., Lee, M.-Y., Ma, D., & Leung, C. (2016) · Chemical Communications · doi:10.1039/c6cc04938a · Cited by 42
Murphy, N. S., Prabhakaran, P., Azzarito, V., Plante, J. P., Hardie, M. J., Kilner, C. A., Warriner, S. L., & Wilson, A. J. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201204098 · Cited by 40
Self-citationSulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors
Tan, C., de Noronha, R. G., Devi, N. S., Jabbar, A. A., Kaluz, Š., Liu, Y., Mooring, S. R., Nicolaou, K. C., Wang, B., & Meir, E. G. V. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.099 · Cited by 34
Brown, C. J., Lim, J., Leonard, T. A., Lim, H., Chia, C. S. B., Verma, C. S., & Lane, D. P. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.045 · Cited by 31
Guo, Y., Scheuermann, T. H., Partch, C. L., Tomchick, D. R., & Gardner, K. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.632786 · Cited by 30
Martin, A. R., Ronco, C., Demange, L., & Benhida, R. (2016) · MedChemComm · doi:10.1039/c6md00432f · Cited by 30
Burslem, G. M., Kyle, H. F., Breeze, A. L., Edwards, T. A., Nelson, A. S., Warriner, S. L., & Wilson, A. J. (2016) · Chemical Communications · doi:10.1039/c6cc01812b · Cited by 29
Self-citationMistry, I. N., & Tavassoli, A. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00219 · Cited by 27
Selective electrochemiluminescent sensing of saccharides using boronic acid-modified coreactant
Li, H., Sedgwick, A. C., Li, M., Blackburn, R. A. R., Bull, S. D., Arbault, S., James, T. D., & Šojić, N. (2016) · Chemical Communications · doi:10.1039/c6cc07030b · Cited by 22
Burslem, G. M., Kyle, H. F., Prabhakaran, P., Breeze, A. L., Edwards, T. A., Warriner, S. L., Nelson, A. S., & Wilson, A. J. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00078a · Cited by 19
Self-citationHangasky, J. A., Taabazuing, C. Y., Martin, C. B., Eron, S. J., & Knapp, M. J. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.10.007 · Cited by 17
Synthesis of Oligobenzamide α-Helix Mimetics
Wilson, A. J., & Burslem, G. M. (2013) · Synlett · doi:10.1055/s-0033-1340342 · Cited by 8
Self-citation
Research works printed but not linked: 2
- Zhong, 1999, Cancer Res., 59, 5830
- Burslem, 2014, Synlett, 25, 324
Cited by
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
Burslem, G. M., & Crews, C. M. (2020) · Cell · doi:10.1016/j.cell.2019.11.031 · Cited by 1,079
“Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction.”
InfluentialSelf-citationTargeting hypoxia-inducible factors: therapeutic opportunities and challenges
Yuan, X., Ruan, W., Bobrow, B., Carmeliet, P., & Eltzschig, H. K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00848-6 · Cited by 245
“Furthermore, considerable effort has been made to identify inhibitors that disrupt the binding of HIF1α with p300, as summarized in a recent review article 150 .”
Wang, H., Dawber, R. S., Zhang, P., Walko, M., Wilson, A. J., & Wang, X. (2021) · Chemical Science · doi:10.1039/d1sc00165e · Cited by 153
Self-citationFlavonoids Targeting HIF-1: Implications on Cancer Metabolism
Samec, M., Líšková, A., Koklesová, L., Meršaková, S., Strnádel, J., Kajo, K., Péč, M. J., Zhai, K., Šmejkal, K., Mirzaei, S., et al. (2021) · Cancers · doi:10.3390/cancers13010130 · Cited by 123
“Structurally, HIF-1 is a heterodimeric protein composed of HIF-α and HIF-β subunits [19].”
BackgroundFialho, M. D. L. S., Jamil, A. H. A., Stannard, G. A., & Heather, L. C. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.024 · Cited by 129
Metadata
- Authors
- Burslem, G. M., Kyle, H. F., Nelson, A., Edwards, T. A., & Wilson, A. J.
- Affiliations
- University of Leeds (GB)
- Corresponding author
- Wilson, Andrew J.
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 8
- Issue
- 6
- Pages
- 4188-4202
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- PMC
- PMC5576430
- OpenAlex
- W2608188974
- Cited by
- 39
- References
- 136
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 5 · 2017: 1
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Update notices
- Open access
- diamond
- doi.org
- Locations
- Chemical Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- European Research Council (ERC-StG-240324, ERC-PoC 632207)
- EPSRC (EP/N025652/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- hypoxia-inducible factor, protein-protein interaction, HIF inhibition, cancer chemotherapy, tumor hypoxia, tumor angiogenesis, HIF-1α, HIF-2α, oncology drug targets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.